February 6th 2025
Cell-line engineering and media formulation improvements are leading to greater performance.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.